AG˹ٷ

STOCK TITAN

Perrigo Co Plc SEC Filings

PRGO NYSE

Welcome to our dedicated page for Perrigo Co Plc SEC filings (Ticker: PRGO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Tracking Perrigo’s global self-care operations means sorting through FDA correspondence, European labelling rules, and dozens of product-recall footnotes scattered across hundreds of pages. Whether you’re checking how inflation squeezed infant-formula margins or comparing store-brand versus branded revenue, the raw SEC data can feel overwhelming.

Stock Titan distills every Perrigo annual report 10-K simplified, each Perrigo quarterly earnings report 10-Q filing, and any Perrigo 8-K material events explained into concise, plain-English highlights. Our AI maps line items to the questions professionals actually ask—“What did Perrigo spend on quality remediation?� or “How did international currency swings hit EPS?”—and flags risk language automatically. Receive Perrigo Form 4 insider transactions real-time, monitor Perrigo executive stock transactions Form 4, and review the Perrigo proxy statement executive compensation without manual searches. For professionals intent on understanding Perrigo SEC documents with AI, our platform layers contextual definitions over GAAP terms and links directly to source exhibits.

Looking for Perrigo insider trading Form 4 transactions ahead of a product launch? Need a quick Perrigo earnings report filing analysis that separates North American from international self-care trends? Or simply want Perrigo SEC filings explained simply so you can brief clients in minutes? Every document arrives within seconds of hitting EDGAR, paired with AI-powered summaries, key-metric tables, and historical comparisons. Spend more time assessing how Perrigo’s affordable OTC strategy drives cash flow and less time sifting through PDFs.

Rhea-AI Summary

Liberty Global Ltd. (Nasdaq: LBTYK) filed a Form 8-K to disclose that its Belgian subsidiary Telenet BV and related guarantors have amended and restated their long-standing senior secured Credit Agreement, first signed in 2007. The new Supplemental Agreement, executed on 30 June 2025, introduces several structural changes designed to streamline liquidity management and extend tenor.

  • Revolving Facility consolidation: The previous Revolving Facilities A & B are collapsed into a single tranche with a new final maturity of 31 May 2029.
  • Incremental liquidity: Aggregate revolving commitments rise by �30.0&Բ;Dz (� US$35.3 million) through the accession of a new lender.
  • Sustainability amendments: Clause 12.13 (Sustainability Adjustments) is revised, signalling an increased link between pricing and ESG performance, although exact KPIs are not detailed in the filing.

The amendment maintains The Bank of Nova Scotia as Facility Agent and KBC Bank NV as Security Agent; all obligors remain wholly-owned within the Liberty Global/Telenet structure, leaving recourse unchanged. Exhibits 4.1 and related XBRL files provide the full legal text. No financial statements accompany the filing, and no immediate draw is disclosed, so the change primarily enhances available liquidity and simplifies covenant tracking without materially altering leverage today.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.66%
Tags
current report

FAQ

What is the current stock price of Perrigo Co Plc (PRGO)?

The current stock price of Perrigo Co Plc (PRGO) is $27.2 as of July 3, 2025.

What is the market cap of Perrigo Co Plc (PRGO)?

The market cap of Perrigo Co Plc (PRGO) is approximately 3.7B.

What products does Perrigo offer?

Perrigo offers a diverse range of over-the-counter self-care products including infant formulas, branded healthcare items, and store-brand OTC products designed to address everyday health needs.

How has Perrigo evolved over the years?

Founded in 1887 as a provider of generic home remedies, Perrigo has transformed into a specialized consumer self-care company focusing on high-quality, affordable OTC health solutions.

What is Perrigo's core business model?

Perrigo’s business model centers on a blend of private-label and national brand products, leveraging operational efficiencies and strategic divestments to concentrate on consumer self-care and OTC health solutions.

Which markets are key to Perrigo's global presence?

Perrigo primarily operates in North America, Europe, and Australia, with additional strategic markets in Asia and other regions, supported by a robust distribution network with major retailers.

How does Perrigo differentiate itself from competitors?

The company differentiates itself through its long-standing focus on affordability, high-quality products, and continuous innovation, coupled with operational efficiency programs and a diversified product mix.

What recent innovations has Perrigo introduced?

Recent innovations include breakthrough products such as the first over-the-counter daily birth control pill, which reflect Perrigo’s commitment to consumer health education and accessibility.

How does Perrigo maintain its commitment to affordable healthcare?

Perrigo reinforces affordability by streamlining its operations, focusing on high-volume store-brand products, and reinvesting cost-saving initiatives into developing and enhancing consumer self-care solutions.

What strategic initiatives support Perrigo's business transformation?

Key initiatives such as Project Energize are instrumental in driving operational efficiencies and margin expansion, supporting the company’s strategic transformation into a pure-play consumer self-care leader.
Perrigo Co Plc

NYSE:PRGO

PRGO Rankings

PRGO Stock Data

3.65B
136.88M
0.34%
101.68%
3.35%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Ireland
DUBLIN 2